智通财经APP讯，维升药业-B(02561)发布公告，Michael Wolff JENSEN先生及Jan Møller MIKKELSEN先生已于股东周年大会结束时退任。为加强董事会的独立性并最终加强公司的管治， Michael Wolff JENSEN先生及Jan Møller MIKKELSEN先生并无于股东周年大会上重选连任。
因此，Michael Wolff JENSEN先生于股东周年大会结束后不再担任提名委员会成员。
于Michael Wolff JENSEN先生退任非执行董事后，彼不再担任董事会主席。董事会进一步宣布，其已建议及选举付山先生继任董事会主席，自股东周年大会结束起生效。
于Michael Wolff JENSEN先生退任非执行董事后，彼于股东周年大会结束后不再担任提名委员会成员及主席。董事会进一步宣布，付山先生已获委任为公司提名委员会成员及主席，自股东周年大会结束起生效。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.